References
- KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary openangle glaucomaArch Ophthalmol200212070171312049574
- KassMAGordonMOGaoFDelaying treatment of ocular hypertension: the ocular hypertension treatment studyArch Ophthalmol201012827628720212196
- Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol19981264985059780094
- HeijlALeskeMCBengtssonBReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
- Collaborative Normal-Tension Glaucoma Study GroupComparison of glaucomatous progression between untreated patients with normaltension glaucoma and patients with therapeutically reduced intraocular pressuresAm J Ophthalmol19981264874979780093
- AsraniSZeimerRWilenskyJLarge diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucomaJ Glaucoma2000913414210782622
- LeePPWaltJWRosenblattLCAssociation between intraocular pressure variation and glaucoma progression: data from a United States chart reviewAm J Ophthalmol200714490190717919446
- CaprioliJColemanALIntraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention studyOphthalmology200811511231129e318082889
- Nouri-MahdaviKHoffmanDColemanALPredictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention StudyOphthalmology20041111627163515350314
- MuschDCGillespieBWNiziolLMIntraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment StudyOphthalmology20111181766177321600658
- BengtssonBLeskeMCHymanLHeijlAFluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trialOphthalmology200711420520917097736
- BengtssonBHeijlADiurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertensionGraefes Arch Clin Exp Ophthalmol200524351351815756577
- LiuJHZhangXKripkeDFWeinrebRNTwenty-four-hour intraocular pressure pattern associated with early glaucomatous changesInvest Ophthalmol Vis Sci2003441586159012657596
- LiuJHBoulignyRPKripkeDFWeinrebRNNocturnal elevation of intraocular pressure is detectable in the sitting positionInvest Ophthalmol Vis Sci2003444439444214507890
- LiuJHKripkeDFTwaMDTwenty-four-hour pattern of intraocular pressure in the aging populationInvest Ophthalmol Vis Sci1999402912291710549652
- LiuJHSitAJWeinrebRNVariation of 24-hour intraocular pressure in healthy individuals: right eye versus left eyeOphthalmology20051121670167516095707
- MosaedSLiuJHWeinrebRNCorrelation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patientsAm J Ophthalmol200513932032415733994
- RealiniTWeinrebNWisniewskiSShort-term repeatability of diurnal intraocular pressure patterns in glaucomatous individualsOphthalmology2011118475120709404
- RealiniTWeinrebRNWisniewskiSRDiurnal intraocular pressure patterns are not repeatable in the short term in healthy individualsOphthalmology20101171700170420557945
- RealiniTBarberLBurtonDFrequency of asymmetric intraocular pressure fluctuations among patients with and without glaucomaOphthalmology20021091367137112093664
- SitAJLiuJHWeinrebRNAsymmetry of right versus left intraocular pressures over 24 hours in glaucoma patientsOphthalmology200611342543016406537
- BhoradeAMGordonMOWilsonBVariability of intraocular pressure measurements in observation participants in the ocular hypertension treatment studyOphthalmology200911671772419243824
- BarnebeyHSOrengo-NaniaSFlowersBEThe safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solutionAm J Ophthalmol20051401715990081
- FellmanRLSullivanEKRatliffMComparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trialOphthalmology2002109998100811986110
- GandolfiSParedesTGoldbergIComparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucomaEur J Ophthalmol201222344422167541
- GoldbergICunha-VazJJakobsenJEComparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertensionJ Glaucoma20011041442211711841
- GrossRLPeaceJHSmithSEDuration of IOP reduction with travoprost BAK-free solutionJ Glaucoma20081721722218414108
- LewisRAKatzGJWeissMJTravoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacyJ Glaucoma2007169810317224758
- NetlandPALandryTSullivanEKTravoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol200113247248411589866
- CaprioliJVarmaRIntraocular pressure: modulation as treatment for glaucomaAm J Ophthalmol2011152340344e221855671
- De MoraesCGHillVTelloCLower corneal hysteresis is associated with more rapid glaucomatous visual field progressionJ Glaucoma6212011 [Epub ahead of print.]
- LichterPRMuschDCGillespieBWInterim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgeryOphthalmology20011081943195311713061